United Kingdom

Huntsman Corp (HUN.N)

HUN.N on New York Stock Exchange

23 Apr 2019
Change (% chg)

$-0.03 (-0.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Huntsman Corporation is a manufacturer of differentiated organic chemical products and of inorganic chemical products. The Company operates all of its businesses through its subsidiary, Huntsman International LLC (Huntsman International). The Company operates through five segments: Polyurethanes, Performance Products, Advanced... (more)


Beta: 2.85
Market Cap(Mil.): $6,612.61
Shares Outstanding(Mil.): 240.02
Dividend: 0.12
Yield (%): 1.81


  HUN.N Industry Sector
P/E (TTM): 15.52 21.38 325.14
EPS (TTM): 1.78 -- --
ROI: 6.21 9.38 10.55
ROE: 26.91 11.20 13.69

Akorn to Delaware justices: Chancery’s MAC opinion is ‘new blueprint for remorseful buyers’

The global pharmaceutical company Fresenius received a rude shock in the summer of 2017 when Akorn, the generic drugmaker Fresenius had agreed to acquire for $4.75 billion, reported its quarterly financial results. The results were terrible – far worse than Fresenius’ gloomiest projection. Fresenius CEO Stephan Sturm considered the Akorn results the biggest personal embarrassment of his career. Within weeks, the company hired Paul Weiss Rifkind Wharton & Garrison to advise it could w

31 Oct 2018

Earnings vs. Estimates